Agenus宣布BOT+BAL聯合免疫療法用於MSS或pMMR轉移性大腸直腸癌的全球第三期BATTMAN試驗完成首例病患招募
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in